Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2010 | 11-2009 | 11-2008 | 11-2007 | 11-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,465 | 1,425 | -726 | -5,005 | -2,811 |
| Depreciation Amortization | 580 | 672 | 678 | 742 | 725 |
| Income taxes - deferred | -1,719 | N/A | N/A | N/A | N/A |
| Accounts receivable | -625 | -484 | -99 | -1,525 | -511 |
| Accounts payable and accrued liabilities | 303 | -86 | -1,056 | 684 | 729 |
| Other Working Capital | -722 | 932 | -39 | 74 | 2,365 |
| Other Operating Activity | 1,056 | 1,289 | 1,856 | 1,626 | 430 |
| Operating Cash Flow | $2,338 | $3,748 | $614 | $-3,404 | $925 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -399 | -450 | -133 | -669 | -991 |
| Purchase Of Investment | -1,035 | -1,010 | -1,125 | -1,002 | -990 |
| Sale Of Investment | 863 | 1,175 | 1,003 | 1,000 | 490 |
| Purchase Sale Intangibles | -249 | -179 | -159 | N/A | N/A |
| Other Investing Activity | -249 | -179 | -159 | 0 | 0 |
| Investing Cash Flow | $-820 | $-464 | $-414 | $-671 | $-1,490 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 1 | 26 | N/A |
| Financing Cash Flow | $N/A | $N/A | $1 | $26 | $N/A |
| Beginning Cash Position | 6,851 | 3,566 | 3,365 | 7,414 | 7,979 |
| End Cash Position | 8,370 | 6,851 | 3,566 | 3,365 | 7,414 |
| Net Cash Flow | $1,519 | $3,284 | $202 | $-4,049 | $-565 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,338 | 3,748 | 614 | -3,404 | 925 |
| Capital Expenditure | -399 | -450 | -133 | -669 | -996 |
| Free Cash Flow | 1,940 | 3,298 | 481 | -4,073 | -71 |